Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

13 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
High body mass index is an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C.
Bressler BL, Guindi M, Tomlinson G, Heathcote J. Bressler BL, et al. Hepatology. 2003 Sep;38(3):639-44. doi: 10.1053/jhep.2003.50350. Hepatology. 2003. PMID: 12939590
High dose intravenous methylprednisolone in the treatment of severe acute respiratory syndrome.
Mishra S, Lee WM, Bressler B, Juvet SC, Hadjiliadis D. Mishra S, et al. Can Respir J. 2004 May-Jun;11(4):311-2. doi: 10.1155/2004/364284. Can Respir J. 2004. PMID: 15254615
Colonoscopic miss rates for right-sided colon cancer: a population-based analysis.
Bressler B, Paszat LF, Vinden C, Li C, He J, Rabeneck L. Bressler B, et al. Gastroenterology. 2004 Aug;127(2):452-6. doi: 10.1053/j.gastro.2004.05.032. Gastroenterology. 2004. PMID: 15300577
Which patients with primary biliary cirrhosis or primary sclerosing cholangitis should undergo endoscopic screening for oesophageal varices detection?
Bressler B, Pinto R, El-Ashry D, Heathcote EJ. Bressler B, et al. Gut. 2005 Mar;54(3):407-10. doi: 10.1136/gut.2004.040832. Gut. 2005. PMID: 15710991 Free PMC article.
Rates of new or missed colorectal cancers after colonoscopy and their risk factors: a population-based analysis.
Bressler B, Paszat LF, Chen Z, Rothwell DM, Vinden C, Rabeneck L. Bressler B, et al. Gastroenterology. 2007 Jan;132(1):96-102. doi: 10.1053/j.gastro.2006.10.027. Gastroenterology. 2007. PMID: 17241863
Pharmacokinetics and response of obese patients with chronic hepatitis C treated with different doses of PEG-IFN alpha-2a (40KD) (PEGASYS).
Bressler B, Wang K, Grippo JF, Heathcote EJ. Bressler B, et al. Br J Clin Pharmacol. 2009 Mar;67(3):280-7. doi: 10.1111/j.1365-2125.2008.03349.x. Br J Clin Pharmacol. 2009. PMID: 19523011 Free PMC article. Clinical Trial.
Clinical practice guidelines for the medical management of nonhospitalized ulcerative colitis: the Toronto consensus.
Bressler B, Marshall JK, Bernstein CN, Bitton A, Jones J, Leontiadis GI, Panaccione R, Steinhart AH, Tse F, Feagan B; Toronto Ulcerative Colitis Consensus Group. Bressler B, et al. Gastroenterology. 2015 May;148(5):1035-1058.e3. doi: 10.1053/j.gastro.2015.03.001. Epub 2015 Mar 4. Gastroenterology. 2015. PMID: 25747596 Review.
The Utility of Infliximab Therapeutic Drug Monitoring among Patients with Inflammatory Bowel Disease and Concerns for Loss of Response: A Retrospective Analysis of a Real-World Experience.
Mitchell RA, Shuster C, Shahidi N, Galorport C, DeMarco ML, Rosenfeld G, Enns RA, Bressler B. Mitchell RA, et al. Can J Gastroenterol Hepatol. 2016;2016:5203898. doi: 10.1155/2016/5203898. Epub 2016 Nov 10. Can J Gastroenterol Hepatol. 2016. PMID: 27957480 Free PMC article.
Treatment Algorithm for Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome Derived from a Canadian National Survey and Needs Assessment on Choices of Therapeutic Agents.
Tse Y, Armstrong D, Andrews CN, Bitton A, Bressler B, Marshall J, Liu LW. Tse Y, et al. Can J Gastroenterol Hepatol. 2017;2017:8612189. doi: 10.1155/2017/8612189. Epub 2017 Feb 8. Can J Gastroenterol Hepatol. 2017. PMID: 28271055 Free PMC article.
Prevalence of Anxiety and Depression in Patients with Inflammatory Bowel Disease.
Byrne G, Rosenfeld G, Leung Y, Qian H, Raudzus J, Nunez C, Bressler B. Byrne G, et al. Can J Gastroenterol Hepatol. 2017;2017:6496727. doi: 10.1155/2017/6496727. Epub 2017 Oct 18. Can J Gastroenterol Hepatol. 2017. PMID: 29181373 Free PMC article.
13 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page